Percheron Therapeutics Limited PERCF
0.00 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.0024 Day range 0.0024
0.0011 52-week range 0.005
- YTD
- -52.00%
- 1 year
- +118.18%
News
proactiveinvestors.com Percheron Therapeutics receives $700,000 R&D rebate to support HMBD-002 cancer program Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has received a $700,000 Research and Development Tax Incentive rebate for the 2026 financial year, providing...
proactiveinvestors.com Percheron Therapeutics Phase II progress highlighted by Edison with 5.5-cent valuation Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) (Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF)) remains on track to begin a Phase II trial of HMBD-002 in...
proactiveinvestors.com Provaris Energy advances hydrogen and CO₂ shipping technologies during June quarter Provaris Energy Ltd (ASX:PV1, OTC:GBBLF, FRA:WS90) made further technical and commercial progress across its compressed hydrogen and liquid carbon dioxide...
proactiveinvestors.com American Rare Earths advances Halleck Creek feasibility and pilot plant plans in pivotal June quarter American Rare Earths Ltd (ASX:ARR, OTCQX:ARRNF) accelerated development of its flagship Halleck Creek Rare Earths Project during the June 2026 quarter,...
proactiveinvestors.com archTIS caps record FY2026 quarter with ARR surge and defence momentum archTIS Ltd (ASX:AR9, OTCQB:ARHLF) closed the June 2026 quarter with annual recurring revenue of $14.8 million, record full-year contracted sales and...
proactiveinvestors.com St George Mining accelerates Araxá development after strong June quarter St George Mining Ltd (ASX:SGQ, FRA:S0G, OTC:SGQMF) advanced the Araxá Niobium-Rare Earths Project during the June 2026 quarter, delivering encouraging...
proactiveinvestors.com Noble Helium strengthens balance sheet and advances Kinambo drilling during June quarter Noble Helium Ltd (ASX:NHE, OTC:NBHEF, FRA:GN1) accelerated preparations for its Kinambo helium drilling campaign during the June 2026 quarter after raising...
proactiveinvestors.com Percheron Therapeutics targets clinical return for HMBD-002 after productive June quarter Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) advanced preparations to return its lead cancer drug HMBD-002 to the clinic during the June 2026 quarter,...
proactiveinvestors.com Altech Batteries sharpens CERENERGY focus after securing grant extension in June quarter Altech Batteries Ltd (ASX:ATC, OTC:ALTHF, FRA:A3Y) used the June 2026 quarter to concentrate its resources on commercialising the CERENERGY® sodium-chloride...